Prostate cancer diagnosing

PSA levels alone aren’t a reliable indicator of prostate cancer—what truly helps is a 3T MRI and, if needed, a biopsy.
Don’t jump into a biopsy just because your PSA is elevated. Many urologists will recommend it quickly, but PSA isn’t cancer-specific, so it doesn’t give a full picture. And randomly sampling the prostate isn’t always the best move.

Instead, consider starting with a 3T MRI (no contrast needed), reviewed by someone experienced. The results will include a Pi-RADS score—only Pi-RADS 4 or 5 lesions typically warrant a biopsy, and even then, it should be targeted, not blind.

If a biopsy is necessary, look into the PrecisionPoint transperineal method. It’s done in-office, no general anesthesia required, and tends to be more cost-effective than traditional options.

Once you have biopsy results, the Gleason score becomes your definitive diagnosis. Unfortunately, if you had a blind biopsy and nothing was found, it might not have been thorough enough for an accurate conclusion.